March 4, 2024
The US Food and Drug Administration (FDA) has granted new approvals for the use of amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) in certain patients with locally advanced […]
March 4, 2024
LILLE, FRANCE — Patients with lung cancer who reside in polluted areas (ie, those affected by PM2.5, PM10, or nitrogen dioxide) have an additional 50% risk […]
March 4, 2024
COPENHAGEN (Reuters) – A group of women from Greenland are seeking compensation from its former colonial ruler Denmark in court over an involuntary birth control campaign […]
March 4, 2024
TOPLINE: People with diabetes who live in small towns in the United States experience higher rates of complications than those living in cities and remote areas. […]
March 4, 2024
Bone-modifying agents — most notably denosumab — are often prescribed to prevent skeletal-related complications in patients with metastatic castration-sensitive prostate cancer, but the drugs are not […]
March 4, 2024
TOPLINE: A new study suggests individualized MRI surveillance of the spine based on patients’ risk for progression after spine stereotactic body radiotherapy (SBRT) can optimize the […]
March 4, 2024
TOPLINE: More than a billion children, adolescents, and adults are living with obesity, globally, with rates of obesity among children and adolescents quadrupling between 1990 and […]
March 4, 2024
A longitudinal study incorporating two validated patient-reported outcome (PRO) tools showed that compared with patients with epidermal chronic cutaneous graft-versus-host disease (GVHD), those with sclerotic and […]
March 1, 2024
The US Food and Drug Administration (FDA) has approved Boston Scientific’s Agent Drug-Coated Balloon (DCB), the first coronary DCB for the treatment of coronary in-stent restenosis […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451
Next page